To evaluate the interaction between metformin and tmCLIC1, three patient-derived GSC-enriched cultures (GBM1-3) and one murine glioma cell line (GL261) lacking CLIC1 expression (Clic1−/−) were generated using CRISPR-Cas9 technology. This evidence concerns the gene CLIC1 and central nervous system cancer.